| May 20, 2011 Seeking Alpha Readers should check out our Seeking Alpha VE Investment App HERE. Free Report Download for Subscribers As a bonus to our Free Weekly Newsletter subscribers, we are now offering a FREE DOWNLOAD of one of our $ 25.00 Detailed Valuation Reports. This week's free download is our report on
Archer Daniels Midland Company (ADM). Archer Daniels Midland Company is a world leader in agricultural processing and fermentation technology. ADM is one of the world's largest processors of soybeans, corn, wheat and cocoa. ADM is also a leader in the production of soybean oil and meal, ethanol, corn sweeteners and flour. The Company works with farmers across the world to turn these crops into soymeal and oil, corn sweeteners, flour, cocoa and chocolate, ethanol and biodiesel, as well as a wide portfolio of other value-added food ingredients, animal nutrition and industrial products. Weekly Subscribers can download a FREE Detailed Valuation Report on ADM HERE. Subscribers can check out the latest figures on Archer Daniels Midland from our models HERE. If you have not subscribed and want to be able to receive a FREE $ 25.00 Detailed Valuation Report, you can subscribe to our Free Weekly Newsletter HERE. ValuEngine Index Overview
| | | | | | DJIA | 12594.84 | 12605.3 | 10.46 | 0.08% | 8.88% | NASDAQ | 2815.9 | 2823.31 | 7.41 | 0.26% | 5.48% | RUSSELL 2000 | 831.75 | 835.16 | 3.41 | 0.41% | 5.24% | S&P 500 | 1334.77 | 1343.6 | 8.83 | 0.66% | 6.84% | ValuEngine Market Overview Summary of VE Stock Universe | Stocks Undervalued | 46.18% | Stocks Overvalued | 53.82% | Stocks Undervalued by 20% | 18.57% | Stocks Overvalued by 20% | 22.92% | . ValuEngine Sector Overview | | | | | | | Multi-Sector Conglomerates | -0.45% | -2.85% | 4.07% | 10.71% overvalued | 32.01% | 28.07 | Utilities | 0.32% | -1.65% | 5.39% | 9.93% overvalued | 23.67% | 23.71 | Oils-Energy | 0.10% | -7.45% | 1.71% | 7.31% overvalued | 43.80% | 47.46 | Consumer Staples | 0.05% | -1.98% | -2.96% | 6.98% overvalued | 19.65% | 21.13 | Business Services | 0.29% | -0.93% | 6.19% | 6.86% overvalued | 13.38% | 37.31 | Retail-Wholesale | -0.40% | -0.48% | 7.06% | 5.09% overvalued | 22.39% | 35.02 | Transportation | 0.25% | -2.43% | -1.00% | 4.69% overvalued | 19.87% | 20.25 | Industrial Products | 0.02% | -4.60% | 3.48% | 4.37% overvalued | 25.23% | 32.00 | Computer and Technology | -0.11% | -3.30% | 9.75% | 4.13% overvalued | 31.96% | 45.11 | Aerospace | 0.72% | -0.58% | 12.62% | 3.81% overvalued | 26.14% | 18.86 | Consumer Discretionary | 0.45% | -0.86% | 6.61% | 3.59% overvalued | 16.42% | 29.85 | Medical | 0.12% | 0.42% | 16.64% | 3.24% overvalued | 19.36% | 34.98 | Finance | 0.02% | -0.10% | 3.33% | 2.73% overvalued | 8.79% | 25.20 | Auto-Tires-Trucks | -0.04% | -5.48% | -6.65% | 1.83% overvalued | 48.51% | 19.56 | Basic Materials | -0.24% | -6.26% | -5.91% | 2.34% undervalued | 44.84% | 23.79 | Construction | 0.49% | -4.17% | -4.19% | 2.48% undervalued | 3.45% | 49.12 | Sector Talk--Medical Stocks Below, we present the latest data on the Medical Sector from our Institutional software package (VEI).
We applied some basic liquidity criteria--share price greater than $3 and average daily volume in excess of 100k shares. Top-Five Medical Sector Stocks--Short-Term Forecast Returns
Ticker | Name | Mkt Price | Valuation(%) | Last 12-M Retn(%) | BTX | BIOTIME INC | 5.03 | N/A | -19.39 | DCTH | DELCATH SYS INC | 5.84 | N/A | -59.16 | TTHI | TRANSITN THERAP | 3.17 | -51.39 | -17.45 | BMTI | BIOMIMETIC THER | 7.95 | -34.48 | -39.36 | DEPO | DEPOMED INC | 8.04 | -11.62 | 125.84 | Top-Five Medical Sector Stocks--Long-Term Forecast Returns
Ticker | Name | Mkt Price | Valuation(%) | Last 12-M Retn(%) | AFFY | AFFYMAX INC | 6.77 | -61.01 | -73.31 | BMTI | BIOMIMETIC THER | 7.95 | -34.48 | -39.36 | BTX | BIOTIME INC | 5.03 | N/A | -19.39 | DCTH | DELCATH SYS INC | 5.84 | N/A | -59.16 | BCRX | BIOCRYST PHARMA | 3.33 | -47.91 | -56.3 | Top-Five Medical Sector Stocks--Composite Score
Ticker | Name | Mkt Price | Valuation(%) | Last 12-M Retn(%) | LLY | LILLY ELI & CO | 38.71 | -11.87 | 20.59 | PDLI | PDL BIOPHARMA | 6.52 | -47.09 | 28.85 | PFE | PFIZER INC | 21.03 | 5.45 | 38.54 | SNY | SANOFI-AVENTIS | 39.23 | 4.38 | 37.22 | AZN | ASTRAZENECA PLC | 51.99 | 3.6 | 29.68 | Top-Five Medical Sector Stocks--Most Overvalued
Ticker | Name | Mkt Price | Valuation(%) | Last 12-M Retn(%) | VRUS | PHARMASSET INC | 99.04 | 300 | 240.79 | NEOP | NEOPROBE CORP | 5.03 | 300 | 197.63 | SVA | SINOVAC BIOTECH | 4.01 | 244.51 | -1.47 | INHX | INHIBITEX INC | 3.51 | 163.13 | 36.05 | REGN | REGENERON PHARM | 54.84 | 148.19 | 95.79 | Seeking Alpha Readers should check out our Seeking Alpha VE Investment App HERE.
Currently, you can research more than 400 ADRs and other foreign stocks
with ValuEngine.com's software and website! We also offer research reports on more than 700 Canadian Companies on our
Research Report Web Page. What's Hot--Suttmeier in the News Chief Market Strategist Makes the Financial Media Rounds ValuEngine.com Chief Market Strategist appeared on the Business News Network and Yahoo Finance this week to offer his market analysis and his take on the continued bad news for the housing market. Suttmeier noted that "Stocks are overvalued fundamentally and overbought technically," and went on to say that "the May 2nd highs for so many [assets classes] marked a significant top for this market." Below, we link to his appearances so you may watch them yourself. Click the images for clips of Suttmeier's latest financial media appearances. Seeking Alpha Readers should check out our Seeking Alpha VE Investment App HERE. 
| 
